Cue Biopharma, Inc.
CUE
$30.50
$0.501.67%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -37.72% | 24.15% | 20.70% | -37.02% | -6.88% |
| Total Receivables | 910.71% | -- | 687.83% | -27.47% | -71.20% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -17.74% | -9.67% | 62.61% | 84.92% | 16.11% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -13.68% | 65.66% | 47.12% | -30.70% | -9.01% |
|
|
|||||
| Total Current Assets | -13.68% | 65.66% | 47.12% | -30.70% | -9.01% |
| Net Property, Plant & Equipment | -42.32% | -12.31% | -10.87% | 6.62% | 1.73% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -79.73% | -60.24% | -58.68% | -68.95% | 45.36% |
| Total Assets | -24.57% | 38.75% | 31.13% | -29.38% | -3.83% |
|
|
|||||
| Total Accounts Payable | 3.31% | -12.08% | 39.85% | -63.73% | -7.14% |
| Total Accrued Expenses | 880.43% | -64.56% | -44.60% | -41.51% | -66.73% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -64.06% | -77.52% | -75.73% | -49.13% | -35.42% |
| Total Finance Division Other Current Liabilities | -89.98% | 87.48% | 6,987.06% | 2,917.76% | 881.45% |
| Total Other Current Liabilities | -89.98% | 87.48% | 6,987.06% | 2,917.76% | 881.45% |
| Total Current Liabilities | 10.20% | -52.31% | -1.42% | -7.54% | 16.98% |
|
|
|||||
| Total Current Liabilities | 10.20% | -52.31% | -1.42% | -7.54% | 16.98% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -53.32% | 967.05% | 127.92% | 102.41% | 58.21% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2,915.79% | -- | -- | -- | -- |
| Total Liabilities | 25.94% | -40.86% | 7.41% | -5.38% | 8.89% |
|
|
|||||
| Common Stock & APIC | 38.94% | 9.58% | 9.89% | 7.15% | 10.26% |
| Retained Earnings | -45.26% | -5.51% | -7.78% | -11.34% | -12.02% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -87.28% | 228.39% | 51.05% | -47.78% | -16.02% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -87.28% | 228.39% | 51.05% | -47.78% | -16.02% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -87.28% | 228.39% | 51.05% | -47.78% | -16.02% |
|
|
|||||